In the PM session, market kept fluctuate at high level and close to market end, it decreased slightly. Till market end, Banking and Medical led the gain. Comprehensive Finance and National Defense led the fall. In total, both markets traded 556.65 billion RMB, down 10.97%.
|Open||Close||% Change||(bn yuan)|
|Sector||Top 1||Led by||Top 2||Led by|
|Downward-leading||Comprehensive Finance||300773||National Defense||300810|
*AutoX Joins Race to get Self Driving ‘Robotaxis’ on Chinese Road
According to a statement emailed to Caixin, AutoX is trialing its “robotaxi” service in the Chinese financial hub of Shanghai, allowing commuters to hail autonomous rides through Alibaba-backed navigation app Amap.
*Starbucks partners with Sequoia Capital
Starbucks on Monday announced a strategic partnership with the leading investment firm Sequoia Capital China to tap into China’s growing technological landscape, and to further digitalize its retail experiences and optimize operations.
*Hog futures approved for Dalian Exchange
*Tencent promotes medical AI to sustain anti-epidemic fight
Chinese tech giant Tencent has utilized its artificial intelligence (AI) technology in the medical sector to aid the fight against the COVID-19 outbreak. Data from the firm showed that so far it has owned more than 300 patents in the medical AI field, ranging from medical auxiliary diagnosis to medical record management and risk monitoring to medical imaging.
Disclosure: Interactive Brokers
Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from Guosen Securities Co., Ltd and is being posted with permission from Guosen Securities Co., Ltd. The views expressed in this material are solely those of the author and/or Guosen Securities Co., Ltd and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.